文献速递肺血管病与心包/心肌炎

Notch3标记的血管平滑肌细胞亚群是闭塞性肺血管病变的起源细胞

A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions.
PubMed 文献 · Circulation · 2020-08-14

该研究在慢性炎症性肺动脉高压小鼠模型中系统绘制肺动脉重构过程,利用遗传谱系追踪、克隆分析、多重原位杂交等方法,发现新生内膜起源于平滑肌细胞而非内皮,Notch3标记的少数平滑肌细胞亚群是新生内膜的主要起源细胞,Notch信号是新生内膜起始细胞筛选所必需,抑制Notch可显著改善肺动脉压力。

要点

  • 新生内膜起源于平滑肌细胞,Notch3标记的少数亚群是其主要起源细胞
  • Notch信号是新生内膜起始细胞筛选所必需,抑制Notch可改善肺动脉压力
  • 该模型由炎症驱动,可产生弥漫闭塞性新生内膜病变,模拟人类PAH病理

核心结论

  • 新生内膜起源于平滑肌细胞而非内皮,Notch3标记的少数平滑肌细胞亚群是闭塞性新生内膜病变的主要起源细胞
  • Notch信号特异性参与新生内膜起始细胞的筛选,Notch抑制可显著改善肺动脉高压动物的肺动脉压力

研究设计与样本

  • 研究采用慢性炎症性肺动脉高压小鼠模型,系统绘制肺动脉逐步重构过程
  • 使用遗传谱系追踪、克隆分析、多重原位杂交、免疫染色、深部共聚焦成像及分阶段药理抑制等方法

主要发现

  • 模型表现出人类疾病病理特征,包括右心室压力升高、中膜增厚、新生内膜病变形成、弹性蛋白分解、支气管循环吻合增加及血管周围炎症
  • 中膜平滑肌细胞广泛增殖使中膜增厚,随后少数平滑肌细胞被选中建立新生内膜,这些新生内膜起始细胞随后大量克隆扩增形成闭塞性病变
  • 正常肺动脉平滑肌细胞群体具有异质性,Notch3标记的少数平滑肌细胞亚群是新生内膜的主要起源细胞

临床怎么用

  • 该研究提示Notch信号通路及Notch3标记的平滑肌细胞亚群可能成为肺动脉高压治疗的新靶点
  • 抑制Notch信号在动物模型中显著改善肺动脉压力,为靶向新生内膜的治疗策略提供依据

局限性

  • 研究基于小鼠模型,结论外推至人类PAH需进一步验证

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by profound vascular remodeling in which pulmonary arteries narrow because of medial thickening and occlusion by neointimal lesions, resulting in elevated pulmonary vascular resistance and right heart failure. Therapies targeting the neointima would represent a significant advance in PAH treatment; however, our understanding of the cellular events driving neointima formation, and the molecular pathways that control them, remains limited. METHODS: We comprehensively map the stepwise remodeling of pulmonary arteries in a robust, chronic inflammatory mouse model of pulmonary hypertension. This model demonstrates pathological features of the human disease, including increased right ventricular pressures, medial thickening, neointimal lesion formation, elastin breakdown, increased anastomosis within the bronchial circulation, and perivascular inflammation. Using genetic lineage tracing, clonal analysis, multiplexed in situ hybridization, immunostaining, deep confocal imaging, and staged pharmacological inhibition, we define the cell behaviors underlying each stage of vascular remodeling and identify a pathway required for neointima formation. RESULTS: Neointima arises from smooth muscle cells (SMCs) and not endothelium. Medial SMCs proliferate broadly to thicken the media, after which a small number of SMCs are selected to establish the neointima. These neointimal founder cells subsequently undergoing massive clonal expansion to form occlusive neointimal lesions. The normal pulmonary artery SMC population is heterogeneous, and we identify a Notch3-marked minority subset of SMCs as the major neointimal cell of origin. Notch signaling is specifically required for the selection of neointimal founder cells, and Notch inhibition significantly improves pulmonary artery pressure in animals with pulmonary hypertension. CONCLUSIONS: This work describes the first nongenetically driven murine model of pulmonary hypertension (PH) that generates robust and diffuse occlusive neointimal lesions across the pulmonary vascular bed and does so in a stereotyped timeframe. We uncover distinct cellular and molecular mechanisms underlying medial thickening and neointima formation and highlight novel transcriptional, behavioral, and pathogenic heterogeneity within pulmonary artery SMCs. In this model, inflammation is sufficient to generate characteristic vascular pathologies and physiological measures of human PAH. We hope that identifying the molecular cues regulating each stage of vascular remodeling will open new avenues for therapeutic advancements in the treatment of PAH.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Steffes LC, Froistad AA, Andruska A, et al. A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions. Circulation. 2020. PMID: 32794408. doi:10.1161/CIRCULATIONAHA.120.045750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。